Ethmin-S 1.5 Injection
Marketer
Doctomed
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ethmin-S 1.5 Injection
Ethmin-S 1.5 Injection, a dual-action medication, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be solely by a healthcare provider. Consistent adherence to the prescribed schedule is crucial; completing the entire treatment course is vital, even with symptom improvement. Premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand immediate medical care. Prior medication disclosure is essential, particularly for pre-existing conditions. Expectant or nursing mothers require physician consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving, drowsiness or dizziness warrants driving cessation. Adequate rest, nutritious food, and hydration support recovery. Monitoring treatment effectiveness may involve laboratory and diagnostic testing.
Uses of Ethmin-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Ethmin-S 1.5 Injection:
Administering this medication will be done by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Ethmin-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ethmin-S 1.5 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
How Ethmin-S 1.5 Injection works:
Ethmin-S 1.5 Injection merges Ceftriaxone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Sulbactam counters bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ethmin-S 1.5 Injection shows no adverse interactions when taken with alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Ethmin-S 1.5 is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, research involving human subjects is scarce.
Breast feedingCAUTION
Administering Ethmin-S 1.5 Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Ethmin-S 1.5 Injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these side effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ethmin-S 1.5 Injection to individuals with renal impairment. Seek medical advice from your physician.
LiverCAUTION
Administering Ethmin-S 1.5 Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the Ethmin-S 1.5 Injection dosage is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ethmin-S 1.5 Injection :
Should you forget a scheduled dose of Ethmin-S 1.5 Injection, seek medical advice.
Facts to Know About Ethmin-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently